🇺🇸 FDA
Patent

US 10022325

Compositions and methods for the treatment of cancer

granted A61KA61K31/704A61K47/10

Quick answer

US patent 10022325 (Compositions and methods for the treatment of cancer) held by BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA expires Mon Jul 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
Grant date
Tue Jul 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/704, A61K47/10, A61K9/0019, A61K9/127